360 Participants Needed

mHealth Technologies for Heart Failure

(iCardia4HF Trial)

Recruiting at 1 trial location
TA
MH
Overseen ByMike Haniff, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 2 & 3
Sponsor: University of Illinois at Chicago
Must be taking: Loop diuretics
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two mobile health technologies to help individuals with chronic heart failure manage their condition more effectively. One treatment, MyApps, uses health apps and devices to track and manage heart health. The other, Text4HF, sends personalized text messages to encourage better self-care habits. Researchers aim to determine if these tools, alone or combined, can reduce hospitalizations and improve daily management of heart failure. Individuals with Stage C heart failure, currently managing their condition with medication and having had recent heart-related hospital stays, might be suitable for this trial. As a Phase 2/3 trial, this research measures the treatment's effectiveness in an initial, smaller group and represents the final step before FDA approval, offering participants a chance to contribute to advancing heart failure care.

Do I need to stop my current medications for this trial?

The trial does not specify if you need to stop your current medications. However, it mentions that participants must be actively treated with oral loop diuretics for chronic heart failure, so you may need to continue those.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that both the MyApps and Text4HF programs are generally safe for people with heart failure. Studies have found that using mobile health apps and devices, like MyApps, is usually easy for people to manage. These tools help track and manage heart health without major issues. Research on similar apps has shown they can reduce risks without causing significant side effects.

The Text4HF program, which sends personalized text messages to encourage better self-care, has also been tested in other studies. These studies found it to be a safe way to support heart health by helping people adhere to their self-care routines, with no major safety concerns.

Using MyApps and Text4HF together is also considered safe. Early findings suggest this combined approach works well and is user-friendly. Overall, these programs appear to be safe options for managing heart failure.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about exploring mHealth technologies like MyApps and Text4HF for heart failure management because these tools offer a fresh approach to self-care. Unlike traditional treatments that mainly focus on medication and regular clinical visits, MyApps uses a combination of health apps and connected devices to help patients monitor and manage their condition daily. Text4HF takes it a step further by providing personalized text messages to boost patients' knowledge and confidence in managing heart failure. Both treatments aim to empower patients with real-time data and support, potentially improving self-management and outcomes in a way that standard care alone might not achieve.

What evidence suggests that this trial's treatments could be effective for heart failure?

Research has shown that mobile health apps like MyApps, which participants in this trial may receive, help people with heart failure take better care of themselves. These apps improve self-care, enabling people to manage their health better and potentially reduce hospital visits. Studies indicate that using these apps and devices can decrease time spent in the hospital and lower the risk of heart-related issues.

Similarly, personalized text messages from programs like Text4HF, another treatment option in this trial, assist heart failure patients by reminding them to follow their care routines. This method encourages healthy habits and helps people maintain consistency in their self-care.

When MyApps and Text4HF are used together, as in one of the trial arms, early research suggests they may be even more effective in enhancing self-care and reducing hospital stays. This combination leverages both technology and personalized messages to promote better health habits.23467

Who Is on the Research Team?

SK

Spyros Kitsiou, PhD

Principal Investigator

University of Illinois Chicago

Are You a Good Fit for This Trial?

This trial is for people with chronic heart failure. Participants should be willing to use mobile health apps and devices daily for self-care, and receive tailored text messages aimed at improving their adherence to self-care routines.

Inclusion Criteria

I have been diagnosed with Stage C heart failure.
I was hospitalized for heart failure or struggle with self-care recently.
My heart's pumping ability is low, or I am on water pills for heart failure.
See 1 more

Exclusion Criteria

Active substance abuse
I have had a heart attack or other heart issue in the last week.
I have had a heart procedure or a CRT device implanted within the last 28 days.
See 12 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Induction

Participants receive the MyApps and/or Text4HF interventions to promote heart failure self-care adherence

3 months
Weekly virtual check-ins

Adoption

Continued use of MyApps and/or Text4HF interventions with reduced frequency of text messages

3 months
Bi-weekly virtual check-ins

Follow-up

Participants are monitored for maintenance efficacy of interventions and health outcomes

6 months
Monthly virtual check-ins

What Are the Treatments Tested in This Trial?

Interventions

  • MyApps
  • Text4HF
Trial Overview The study tests two interventions: 'MyApps', which involves using mHealth apps and devices for daily heart failure care, and 'Text4HF', a series of personalized text messages. It will assess if these can improve self-care and reduce hospitalization or death from cardiovascular causes.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Active Control
Group I: Text4HFExperimental Treatment1 Intervention
Group II: MyApps + Text4HFExperimental Treatment1 Intervention
Group III: MyAppsExperimental Treatment1 Intervention
Group IV: Enhanced usual careActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Published Research Related to This Trial

The Care4myHeart app, designed for self-management of heart failure, received an overall quality score of 3.53 out of 5, indicating it is considered 'acceptable' by users, particularly excelling in aesthetics and information delivery.
While the app showed potential for improving self-management through features like weight tracking and data visualization, its impact on health behavior change was perceived as low, highlighting a barrier to adoption due to the need for integration into existing routines.
Patients' Experiences of Using a Consumer mHealth App for Self-Management of Heart Failure: Mixed-Methods Study.Woods, LS., Duff, J., Roehrer, E., et al.[2020]
The iHeartU mobile health app was developed to enhance self-management for heart failure patients, aiming to improve communication with healthcare providers and reduce hospital readmission rates.
Initial usability testing is underway, and the app is designed to be user-friendly and accessible, particularly for low-income patients, potentially leading to better health outcomes and lower healthcare costs.
A Patient-Centered Mobile Phone App (iHeartU) With a Virtual Human Assistant for Self-Management of Heart Failure: Protocol for a Usability Assessment Study.Zhang, L., Babu, SV., Jindal, M., et al.[2020]
This review analyzed 18 studies on mobile health (mHealth) apps for heart failure management, revealing that many studies had low-quality designs and small sample sizes, which raises concerns about their reliability and efficacy.
Despite the challenges, the review suggests that mHealth apps could provide a cost-effective solution for heart failure self-care, offering patients 24/7 access to symptom monitoring and promoting engagement in their own health management.
Mobile Phone Apps to Support Heart Failure Self-Care Management: Integrative Review.Athilingam, P., Jenkins, B.[2023]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39813671/
Patient-Centered mHealth Intervention to Improve Self-Care in ...The primary efficacy outcome was change in HF self-care subscale scores (maintenance, symptom perception, and self-care management) at 8 weeks, ...
iCardia4HF: Multi-component mHealth Intervention for ...The main questions this study aims to answer are: Can the use of consumer mHealth apps and devices (MyApps) improve heart failure self-care and reduce days lost ...
Evaluation of Heart Failure Apps to Promote Self-CareWe conducted a systematic search of all apps available exclusively for HF self-care across Google Play and the App Store.
mHealth Technologies for Heart Failure (iCardia4HF Trial)Research suggests that mobile health apps can help people with heart failure manage their condition better by reducing hospital visits and improving their ...
Patient-Centered mHealth Intervention to Improve Self ...MyApps consisted of 3 popular consumer-grade mHealth apps (Heart Failure ... heart failure based on the data I collect from the mobile app and smart devices ...
Patients' Experiences Using a Mobile Health App for Self ...Publicly available patient-focused mobile health (mHealth) apps are being increasingly integrated into routine heart failure (HF)–related ...
Effectiveness of mobile health applications on clinical ...Mobile health apps have the potential to lower the incidence of major adverse cardiac events (MACEs), readmission rates, and blood lipids in patients with CHD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security